📘 LIVER CIRRHOSIS — COMPLETE &
COMPREHENSIVE REVIEWER
(Nursing-Focused)
I. DEFINITION
Liver cirrhosis is the chronic, progressive, irreversible scarring (fibrosis) of the liver due to
long-term damage, leading to distorted liver architecture, nodular regeneration, and
impaired liver function.
II. ETIOLOGY (Causes)
Most common causes:
● Alcoholic liver disease (long-term alcohol intake)
● Chronic viral hepatitis (HAV—rare, HBV, HCV most common)
● Non-alcoholic fatty liver disease (NAFLD/NASH)
● Autoimmune hepatitis
● Biliary cirrhosis (Primary or Secondary)
● Genetic/Metabolic causes
○ Hemochromatosis (↑ iron)
○ Wilson disease (↑ copper)
○ Alpha-1 antitrypsin deficiency
● Drugs/Toxins
○ Acetaminophen overdose
○ Methotrexate
○ Chronic alcohol use
III. PATHOPHYSIOLOGY (Simplified Flow)
Liver injury → Chronic inflammation → Fibrosis → Formation of regenerative nodules →
Compression of hepatic vasculature → Portal hypertension + Impaired liver function →
Systemic complications (ascites, varices, encephalopathy, etc.)
IV. CLINICAL MANIFESTATIONS
A. Early Symptoms
● Fatigue
● Anorexia
● Weight loss
● Nausea/vomiting
● Right upper quadrant discomfort
B. Late Symptoms (Decompensated Cirrhosis)
Due to Portal Hypertension
● Ascites
● Esophageal & gastric varices → GI bleeding
● Splenomegaly
● Caput medusae
● Hemorrhoids
Due to Impaired Liver Function
● Jaundice
● Pruritus
● Bruising & bleeding (↓ clotting factors)
● Hepatic encephalopathy → confusion, asterixis, coma
● Hepatorenal syndrome
● Hepatopulmonary syndrome
Skin Changes
● Spider angiomas
● Palmar erythema
● Gynecomastia (↑ estrogen)
● Testicular atrophy
Cardiovascular
● Hypotension
● Tachycardia
V. COMPLICATIONS (Must Know for
Exams)
1. Portal Hypertension
↑ resistance to portal blood flow
➡ Risk for variceal bleeding
➡ Splenomegaly (↓ platelets)
2. Ascites
Fluid accumulation in peritoneal cavity
Major risk: spontaneous bacterial peritonitis (SBP)
3. Esophageal Varices
Can rupture and cause life-threatening bleeding
4. Hepatic Encephalopathy
Ammonia buildup → altered mental status
5. Coagulopathy
↓ vitamin K & clotting factor production
6. Hepatorenal Syndrome
Kidney failure due to severe liver failure
7. Hepatocellular Carcinoma (HCC)
VI. DIAGNOSTICS
A. Laboratory Findings
● ↑ AST, ALT (mild)
● ↑ Bilirubin
● ↑ Ammonia
● ↑ PT/INR
● ↓ Albumin
● ↓ Platelets (splenomegaly)
● ↓ RBC/WBC (hypersplenism)
B. Imaging
● Ultrasound – first line
● CT/MRI – liver nodularity, portal hypertension
● Fibroscan – measures stiffness
● Endoscopy – varices
C. Procedures
● Paracentesis for ascitic fluid
● Liver biopsy – definitive but not always needed
VII. MANAGEMENT AND TREATMENT
A. General Management (ALL PATIENTS)
● Avoid alcohol
● Manage underlying cause (hepatitis treatment, avoid hepatotoxic drugs)
● Low-sodium diet (≤ 2 g/day)
● Fluid restriction if hyponatremic
● Vaccines: Hep A, Hep B, Influenza, Pneumococcal
VIII. PRIORITY NURSING INTERVENTIONS
1. Ascites Management
● Daily weights; measure abdominal girth
● Low-sodium diet
● Administer:
○ Spironolactone (first-line diuretic)
○ Furosemide
● Monitor electrolytes
● Prepare for paracentesis
○ Void before procedure
○ Monitor for hypovolemia, bleeding
● Assess for SBP:
○ Fever, abdominal pain, rebound tenderness
2. Variceal Bleeding Prevention & Management
● Administer beta-blockers (Propranolol)
● Avoid straining, vomiting
● Manage active bleeding:
○ Endoscopic band ligation
○ Octreotide IV
○ Blood transfusion
3. Hepatic Encephalopathy
● Assess LOC, asterixis
● Administer:
○ Lactulose → excretes ammonia via stool
○ Rifaximin → decreases ammonia-producing bacteria
● Avoid sedatives
● Monitor serum ammonia
4. Coagulopathy & Bleeding Risk
● Avoid IM injections
● Apply pressure on venipuncture
● Administer vitamin K
● Monitor PT/INR
5. Nutrition
● High-calorie, high-protein (unless encephalopathy)
● Small frequent meals
● Low-sodium
● Avoid alcohol, spicy foods, liver-toxic meds
6. Skin Integrity
● Manage pruritus
● Use emollients
● Trim nails; prevent scratching
7. Psychosocial Support
● Anxiety related to chronic illness
● Family education
● Support for alcohol cessation
IX. MEDICATIONS TO KNOW
For Ascites
● Spironolactone
● Furosemide
For Varices
● Propranolol
● Octreotide
For Encephalopathy
● Lactulose
● Rifaximin
For Coagulopathy
● Vitamin K
For Pruritus
● Cholestyramine
X. LIFESTYLE & PATIENT EDUCATION
● Strict alcohol cessation
● Avoid NSAIDs (risk of bleeding)
● Avoid acetaminophen in high doses
● Report black stools, vomiting blood
● Avoid raw shellfish (vibrio infection risk)
● Daily weights
● Medication adherence
XI. NANDA NURSING DIAGNOSES
(Examples)
● Fluid volume excess related to portal hypertension
● Risk for bleeding related to coagulopathy
● Confusion related to hepatic encephalopathy
● Imbalanced nutrition: less than body requirements
● Activity intolerance
● Impaired skin integrity
📘 HEPATIC ENCEPHALOPATHY (HE)
A life-threatening neuropsychiatric complication of liver failure
I. DEFINITION
Hepatic Encephalopathy (HE) is a reversible decline in brain function caused by liver
dysfunction, leading to accumulation of ammonia and other neurotoxins in the blood.
II. CAUSES
Primary cause:
● Cirrhosis → damaged liver cannot detoxify ammonia
Precipitating Factors (VERY IMPORTANT IN EXAMS):
1. GI bleeding
2. Infection (UTI, SBP)
3. High protein intake (less common)
4. Constipation → ↑ ammonia absorption
5. Electrolyte imbalances
○ Hypokalemia
○ Hyponatremia
○ Metabolic alkalosis
6. Dehydration
7. Benzodiazepines or sedatives
8. Alcohol intake
9. TIPS procedure (shunting ammonia-rich blood into systemic circulation)
III. PATHOPHYSIOLOGY (Simple Flow)
Liver dysfunction → ↓ detoxification of ammonia → ammonia crosses blood-brain barrier →
astrocyte swelling → cerebral edema → altered neurotransmission → confusion → coma
IV. STAGES (West Haven Criteria — MUST
KNOW)
Stage 0:
Minimal HE; subtle changes only
Stage 1: Mild
● SLEEP DISTURBANCE
● Slight confusion
● Personality changes
● Shortened attention span
Stage 2: Moderate
● Lethargy
● Disorientation (time)
● Inappropriate behavior
● Asterixis (“liver flap”)
● Slow speech
Stage 3: Severe
● Marked confusion
● Somnolence but arousable
● Disorientation (time, place, person)
● Clonus
Stage 4: Coma
● Unresponsive
● Decerebrate posture possible
● Needs ICU care
V. CLINICAL MANIFESTATIONS
Neurologic
● Confusion
● ↓ LOC
● Asterixis (flapping tremor)
● Hyperreflexia
● Behavior/personality changes
● Difficulty concentrating
● Seizures (rare)
● Coma
Other Manifestations
● Musty, sweet breath odor (fetor hepaticus)
● Sleep pattern reversal
● Fatigue
● Slurred speech
VI. DIAGNOSTICS
● Serum ammonia ↑
(Note: Level does not always correlate with severity)
● Liver function tests
(↑ bilirubin, ↑ PT/INR, ↓ albumin)
● Electrolytes (look for precipitating imbalances)
● ABG (metabolic alkalosis can worsen HE)
● CT head (rule out stroke if indicated)
● Ultrasound abdomen (evaluate liver disease)
VII. MANAGEMENT & TREATMENT
A. First-Line Treatment
1. Lactulose (mainstay)
● Traps ammonia in colon → excreted in stool
● Goal: 2–3 soft stools/day
● Monitor:
○ Electrolytes (risk of hypokalemia)
○ Dehydration
2. Rifaximin (Xifaxan)
● Decreases ammonia-producing gut bacteria
● Used if:
○ Refractory to lactulose
○ Recurrent HE
B. Correct Precipitating Factors
● Treat GI bleed
● Treat infection (SBP – Cefotaxime)
● Correct electrolytes
○ Potassium
○ Sodium
● Manage constipation
● Stop sedatives, opioids, benzodiazepines
● Manage renal failure
C. Nutrition
Old guideline: protein restriction
New guideline: Do NOT restrict protein unless severe HE
● High-carb diet
● Moderate protein (1.2–1.5 g/kg)
● Prefer plant-based protein (↓ ammonia)
● Small frequent meals
D. ICU Management for Severe HE (Stages 3–4)
● Airway protection if ↓ LOC
● Prevent aspiration
● Monitor ICP (cerebral edema risk)
● Continuous neuro assessment
VIII. NURSING INTERVENTIONS
1. Monitor Mental Status
● Glasgow Coma Scale
● Monitor confusion, orientation
● Check for asterixis
2. Administer Medications
● Lactulose
○ Document stool output
○ Hold if diarrhea is severe
● Rifaximin
● Electrolyte replacements
3. Safety
● Fall precautions
● Aspiration precautions
● Side rails up
● Assist with ADLs
4. Nutritional Support
● Small frequent meals
● Avoid alcohol
● Use soft diet if risk for aspiration
5. Manage Ammonia Levels
● Avoid constipation
● Encourage hydration
● Monitor stool pattern
6. Monitor for Complications
● GI bleeding
● Infection (SBP)
● Cerebral edema
● Hypokalemia
● Dehydration
IX. PATIENT EDUCATION
● Avoid alcohol entirely
● Adhere to lactulose regimen
● Do not skip bowel movements
● Report:
○ Confusion
○ Blood in stool/vomit
○ Fever
○ Severe diarrhea
● Avoid sedatives unless prescribed
● Maintain low-sodium diet (if cirrhosis with ascites)
X. NANDA NURSING DIAGNOSES
● Risk for Injury related to altered mental status
● Acute Confusion related to ammonia accumulation
● Ineffective Airway Clearance related to decreased LOC
● Imbalanced Nutrition: less than body requirements
● Risk for Aspiration
● Impaired Memory
📘 ESOPHAGEAL VARICES — COMPLETE
COMPREHENSIVE REVIEWER
I. DEFINITION
Esophageal varices are dilated veins in the lower esophagus caused by portal
hypertension, usually from liver cirrhosis.
They are fragile and may rupture, causing life-threatening upper GI bleeding.
II. CAUSES
Most common cause:
● Cirrhosis with portal hypertension (alcoholic, hepatitis B/C, NAFLD)
Other causes:
● Portal vein thrombosis
● Schistosomiasis (endemic countries)
● Severe right-sided heart failure (rare)
III. PATHOPHYSIOLOGY (Simplified Flow)
Cirrhosis → ↑ resistance in portal venous system → blood diverted to collateral veins → dilation
of esophageal veins → esophageal varices → high risk of rupture → massive GI bleeding
IV. RISK FACTORS FOR BLEEDING
● Large varices
● High portal pressure
● Red wale markings on endoscopy
● Severe liver dysfunction (Child-Pugh B/C)
● Alcohol intake
● Vomiting/straining
● NSAID use (irritates mucosa)
V. CLINICAL MANIFESTATIONS
A. If Unruptured
Usually asymptomatic
May have:
● Signs of portal hypertension (ascites, splenomegaly)
● Signs of liver failure (jaundice, spider angiomas)
B. If Bleeding (medical emergency!)
● Hematemesis (vomiting bright red blood)
● Melena (black stool)
● Coffee-ground emesis
● Hypotension
● Tachycardia
● Cold, clammy skin
● Dizziness / syncope
● Shock
VI. DIAGNOSTICS
1. Endoscopy (EGD) — GOLD STANDARD
● Identifies varices
● Allows banding or sclerotherapy
2. Laboratory Tests
● CBC (↓ Hgb, Hct; ↓ platelets)
● Coagulation profile: ↑ PT/INR, ↓ clotting factors
● LFTs (AST, ALT, bilirubin)
● Type and crossmatch (if bleeding)
3. Ultrasound with Doppler
● Assesses portal hypertension
● Detects splenomegaly, ascites
VII. MANAGEMENT
A. PREVENTION (PRIMARY
PROPHYLAXIS)
For patients with cirrhosis to prevent first bleed:
1. Non-selective Beta Blockers
● Propranolol
● Nadolol
→ Reduces portal pressure
→ Target HR: 55–60 bpm
2. Endoscopic Variceal Ligation (EVL)
● Banding of varices
● Preferred if beta-blockers are contraindicated
B. ACUTE BLEEDING MANAGEMENT
(LIFE-THREATENING)
1. AIRWAY FIRST (PRIORITY)
● Intubation if massive bleeding
● Prevent aspiration
2. Resuscitation
● 2 large-bore IV lines
● IV fluids, blood transfusion
● Maintain Hgb around 7–8 g/dL
3. MEDICATIONS
a. Octreotide (drug of choice)
● Potent splanchnic vasoconstrictor
● ↓ portal blood flow
b. Vasopressin (rare, more side effects)
● With nitroglycerin to reduce ischemia
c. Proton Pump Inhibitors (PPI)
● Protect gastric mucosa (e.g., Pantoprazole)
d. Antibiotics
● IV Ceftriaxone
● Prevents infection and SBP (spontaneous bacterial peritonitis)
4. ENDOSCOPIC THERAPY
● Endoscopic Band Ligation (first-line)
● Endoscopic Sclerotherapy (second-line)
5. BALLOON TAMPONADE (severe, temporary)
● Sengstaken-Blakemore tube
● ONLY if endoscopy not available
6. TIPS (Transjugular Intrahepatic Portosystemic Shunt)
● Last resort if:
○ Bleeding persists
○ Recurrent variceal hemorrhage
● Risk: hepatic encephalopathy
C. SECONDARY PROPHYLAXIS (AFTER A
BLEED)
To prevent rebleeding:
● Beta-blockers PLUS endoscopic band ligation
● Repeat EVL every 1–2 weeks until varices disappear
VIII. NURSING INTERVENTIONS
During Active Bleeding
● Maintain airway; prepare for intubation
● Monitor vital signs (shock)
● Insert and monitor large-bore IV lines
● Prepare for urgent endoscopy
● Keep NPO
● Monitor I&O
● Provide O2
● Check for signs of hypovolemia
● Prepare blood products
Post-Bleeding / Long-term Management
● Administer beta-blockers
● Educate patient about:
○ Avoid alcohol
○ Avoid heavy lifting/straining
○ Avoid rough foods (chips, crackers)
● Monitor for melena and hematemesis
● Assess for hepatic encephalopathy
● Maintain low-sodium diet (if ascites)
● Avoid NSAIDs (can worsen bleeding)
● Support smoking/alcohol cessation
IX. COMPLICATIONS
● Hypovolemic shock
● Hepatic encephalopathy
● Aspiration pneumonia
● Multi-organ failure
● Rebleeding
● Death if uncontrolled
X. NANDA NURSING DIAGNOSES
● Risk for Bleeding related to portal hypertension
● Deficient Fluid Volume related to blood loss
● Risk for Shock
● Ineffective Airway Clearance (during active bleed)
● Acute Pain
● Anxiety related to life-threatening condition
📘 REVIEWER: Impaired Esophageal
Motility
I. Definition
Impaired esophageal motility refers to abnormal movement, coordination, or strength of
muscular contractions in the esophagus, resulting in difficulty swallowing (dysphagia), chest
pain, regurgitation, or other gastrointestinal symptoms. It may involve the upper esophageal
sphincter (UES), esophageal body, and lower esophageal sphincter (LES) dysfunction.
II. Relevant Anatomy & Physiology
A. Esophagus
● A muscular tube (~25 cm) connecting the pharynx to the stomach.
● Composed of:
○ Upper third: striated muscle (voluntary control)
○ Middle third: mixed striated and smooth muscle
○ Lower third: smooth muscle (involuntary control)
B. Sphincters
● Upper Esophageal Sphincter (UES): opens to allow food into the esophagus.
● Lower Esophageal Sphincter (LES): relaxes to let food into the stomach and contracts
to prevent reflux.
C. Normal Swallowing Mechanism
1. Oral Phase: voluntary chewing and food preparation
2. Pharyngeal Phase: involuntary reflex that closes airway and moves bolus through UES
3. Esophageal Phase: peristaltic waves move food toward stomach; LES relaxes
III. Pathophysiology
Impaired motility arises from dysfunction in:
● Neural control (vagal nerve, enteric plexus)
● Muscle coordination
● LES relaxation/contraction mechanics
Leading to:
● Incomplete peristalsis
● Non-propulsive contractions
● LES that fails to relax (achalasia)
● Hypertensive LES or spasm
IV. Causes (Etiologies)
A. Primary Esophageal Motility Disorders
1. Achalasia
○ Loss of inhibitory nerves → LES fails to relax
2. Diffuse Esophageal Spasm (DES)
○ Uncoordinated unorganized contractions
3. Nutcracker Esophagus
○ High-pressure peristaltic waves
4. Hypercontractile (Jackhammer) Esophagus
○ Excessively strong contractions
B. Secondary Causes
1. Scleroderma (Systemic sclerosis)
○ Smooth muscle atrophy → weak peristalsis
2. Chagas Disease
○ Trypanosoma cruzi infection
3. Diabetes Mellitus
○ Neuropathy affecting esophageal nerves
4. Gastroesophageal Reflux Disease (GERD)
○ May contribute to motility abnormalities
5. Post-surgical/Neurologic Conditions
○ Stroke, Parkinson’s disease, multiple sclerosis
V. Clinical Manifestations
A. Dysphagia
● Difficulty swallowing solids and/or liquids
● Progressive or intermittent
B. Regurgitation
● Backflow of undigested food
C. Chest Pain
● Non-cardiac, may mimic angina (especially with spasm)
D. Heartburn & Reflux Symptoms
(Typically associated with secondary disorders and LES dysfunction)
E. Weight Loss
● Due to poor intake and fear of eating
VI. Diagnostic Evaluation
A. Structural Evaluation
1. Upper GI Endoscopy
○ Rules out strictures, masses, reflux esophagitis
2. Barium Swallow (Esophagram)
○ Classic findings:
■ Achalasia: “Bird’s beak”
■ DES: Corkscrew esophagus
■ Scleroderma: Dilated atonic esophagus
B. Functional Testing
1. Esophageal Manometry (Gold Standard)
○ Measures pressure & coordination of esophageal motility
○ Distinguishes:
■ Achalasia types (I, II, III)
■ Spasm
■ Hypotensive peristalsis
2. 24-Hour pH Monitoring
○ For associated gastroesophageal reflux
C. Additional Studies
● CT scan (if mass or extrinsic compression suspected)
● Blood tests (for autoimmune or infectious causes)
VII. Management
A. Goals
1. Relieve symptoms
2. Improve swallowing & esophageal emptying
3. Prevent complications (aspiration, malnutrition)
VIII. Treatment Modalities
A. Medical Therapies
1. Smooth Muscle Relaxants
○ Calcium channel blockers (nifedipine)
○ Nitrates
○ Phosphodiesterase inhibitors (e.g., sildenafil)
2. Botulinum Toxin Injection
○ Reduces LES pressure (often used in high-risk surgical patients)
3. Prokinetic Agents
○ Metoclopramide (limited utility in primary motility disorders)
B. Surgical/Procedural Interventions
1. Pneumatic Dilation
○ Balloon dilation of LES
○ Common in achalasia
2. Heller Myotomy
○ Surgical cut of LES fibers
○ Often combined with partial fundoplication
3. Peroral Endoscopic Myotomy (POEM)
○ Endoscopic approach to LES and spastic segments
4. Dilatation for Strictures
○ If present
C. Lifestyle & Dietary Modifications
● Eat smaller, frequent meals
● Chew thoroughly, drink fluids with meals
● Sleep with head elevated
● Avoid:
○ Very hot/cold foods
○ Alcohol
○ Citrus/spicy foods if reflux exists
IX. Complications
● Aspiration Pneumonia
● Malnutrition/Weight Loss
● Esophageal Dilatation
● Esophageal Perforation (with aggressive dilation)
● Reflux Esophagitis / Barrett’s Esophagus
○ Especially after LES weakening procedures
X. Differential Diagnoses
● Esophageal stricture (from GERD, radiation, caustic ingestion)
● Esophageal cancer
● Zenker’s diverticulum
● GERD without motility disorder
● Functional dysphagia
XI. Nursing Assessment
Assess for:
✔ Dysphagia (solids vs liquids vs both)
✔ Frequency of regurgitation
✔ Pain with swallowing (odynophagia)
✔ Weight changes
✔ Respiratory symptoms (cough, wheeze, recurrent pneumonia)
✔ Hydration status
XII. Nursing Interventions
A. Immediate Care
● Maintain patent airway
● Monitor signs of aspiration
● Provide liquid supplements if needed
● Facilitate safe swallowing strategies
B. Patient Education
● Encourage slow, mindful eating
● Reinforce dietary modifications
● Avoid trigger foods and smoking
● Teach medications & side effects
● When to seek help (worsening dysphagia, inability to swallow liquids)
XIII. Case Application (Practice)
Sample NCLEX-Style Questions
1. A patient with achalasia complains of progressive difficulty swallowing both solids and
liquids. Which diagnostic test is most definitive?
○ Answer: Esophageal manometry
2. What is the primary goal of pneumatic dilation in achalasia?
○ Answer: Decrease LES pressure to improve esophageal emptying
3. A patient reports regurgitation of undigested food at night with cough. What complication
should the nurse suspect?
○ Answer: Aspiration pneumonia
XIV. Summary
Component Key Points
Definition Abnormal esophageal muscle movement
Main Symptoms Dysphagia, chest pain, regurgitation
Gold Standard Dx Esophageal manometry
Common Disorders Achalasia, spasms, scleroderma
Treatment Relaxants, dilation, myotomy
Nursing Focus Swallowing safety, symptom monitoring,
patient education
📘 REVIEWER: HIATAL HERNIA
I. Definition
A hiatal hernia occurs when part of the stomach protrudes upward through the esophageal
hiatus of the diaphragm into the thoracic cavity, disrupting the normal gastroesophageal
junction and predisposing the patient to gastroesophageal reflux.
II. Relevant Anatomy & Physiology
A. Diaphragm
● Dome-shaped muscle separating thoracic and abdominal cavities
● Contains an opening called the esophageal hiatus
B. Gastroesophageal Junction
● Junction of esophagus and stomach
● Supported by:
○ Lower esophageal sphincter (LES)
○ Diaphragmatic crura
● Prevents reflux of gastric contents
III. Types of Hiatal Hernia
1. Sliding Hiatal Hernia (Type I) – MOST COMMON
● Gastroesophageal junction slides above the diaphragm
● LES displaced into thorax
● Strongly associated with GERD
📌 Often asymptomatic
2. Paraesophageal (Rolling) Hiatal Hernia (Types II–IV)
● Stomach herniates beside the esophagus
● LES remains in normal position
● Higher risk for strangulation
📌 Medical emergency if ischemia occurs
IV. Etiology / Risk Factors
● Increased intra-abdominal pressure:
○ Obesity
○ Pregnancy
○ Ascites
○ Chronic coughing
○ Heavy lifting
○ Straining (constipation)
● Aging (weakening of diaphragmatic muscles)
● Congenital diaphragmatic weakness
● Trauma or surgery
V. Pathophysiology
1. Weakening or widening of the esophageal hiatus
2. Stomach herniates upward
3. LES function impaired
4. Gastric acid refluxes into esophagus
5. Esophageal mucosal irritation → inflammation
VI. Clinical Manifestations
A. Common Symptoms (especially Sliding Type)
● Heartburn (pyrosis)
● Regurgitation
● Dysphagia
● Epigastric or chest pain
● Belching
● Early satiety
B. Severe Symptoms (Paraesophageal Hernia)
● Severe chest pain
● Vomiting
● GI bleeding
● Dyspnea
● Signs of strangulation:
○ Sudden pain
○ Hypotension
○ Tachycardia
🚨 Medical emergency
VII. Diagnostic Evaluation
A. Imaging
● Barium swallow (Upper GI series) – diagnostic of choice
● Shows herniation and reflux
B. Endoscopy (EGD)
● Evaluates esophagitis, ulceration, Barrett’s esophagus
C. Esophageal Manometry
● Assesses LES pressure and motility
D. pH Monitoring
● Confirms acid reflux
VIII. Medical Management
A. Pharmacologic Therapy
● Proton Pump Inhibitors (PPIs): omeprazole
● H2 receptor blockers: famotidine
● Antacids
● Prokinetic agents (selected cases)
📌 Medications treat symptoms, not the hernia
B. Lifestyle & Dietary Modifications
● Small, frequent meals
● Avoid lying down 2–3 hours after eating
● Elevate head of bed (6–8 inches)
● Avoid:
○ Spicy foods
○ Fatty foods
○ Caffeine
○ Chocolate
○ Alcohol
● Weight loss
● Smoking cessation
IX. Surgical Management
Indicated when:
● Severe GERD unresponsive to medication
● Paraesophageal hernia
● Complications present
Common Procedures
● Nissen fundoplication
● Hiatal hernia repair
● Laparoscopic approaches preferred
X. Complications
● Gastroesophageal reflux disease (GERD)
● Esophagitis
● Esophageal ulceration
● Barrett’s esophagus
● Aspiration pneumonia
● Gastric volvulus (paraesophageal)
● Strangulation & ischemia
XI. Nursing Assessment
Assess for:
● Heartburn frequency and severity
● Dysphagia
● Regurgitation
● Chest pain (rule out cardiac causes)
● Respiratory symptoms
● Nutritional status
● Medication adherence
XII. Nursing Interventions
A. Independent
● Encourage upright positioning after meals
● Educate on dietary modifications
● Promote weight reduction
● Teach proper medication timing
B. Collaborative
● Administer prescribed acid-suppressive medications
● Monitor for signs of GI bleeding
● Prepare patient for diagnostic procedures
● Post-operative care after fundoplication
XIII. Patient Education
● Avoid tight clothing
● Avoid bending or lifting after meals
● Recognize warning signs:
○ Severe chest pain
○ Vomiting blood
○ Black stools
○ Sudden difficulty swallowing
XIV. NCLEX-Style Key Points
✔ Sliding hiatal hernia → GERD
✔ Paraesophageal hernia → strangulation risk
✔ Barium swallow = best diagnostic test
✔ Elevate HOB, not pillows
✔ Surgery for paraesophageal or refractory GERD
XV. Comparison Table
Feature Sliding Hernia Paraesophageal Hernia
Frequency Common Rare
GERD Yes Minimal
Risk of strangulation Low High
Surgery needed Rare Often
XVI. Summary
Hiatal hernia is a structural defect allowing stomach herniation through the diaphragm. While
often asymptomatic, it can lead to GERD and serious complications. Nursing care focuses on
symptom management, education, prevention of reflux, and early detection of
complications.
📘 REVIEWER: DIVERTICULAR DISEASE
I. Definition
Diverticular disease refers to conditions involving the formation and inflammation of
diverticula, which are small pouch-like herniations of the intestinal wall, most commonly in the
sigmoid colon.
It includes:
● Diverticulosis – presence of diverticula (non-inflamed)
● Diverticulitis – inflammation and/or infection of diverticula
II. Relevant Anatomy & Physiology
● The colon absorbs water and electrolytes and forms stool
● Diverticula form at weak points where blood vessels penetrate the bowel wall
● Most common site: sigmoid colon (↑ pressure area)
III. Types of Diverticular Disease
1. Diverticulosis
● Multiple diverticula present
● Often asymptomatic
● Usually discovered incidentally
2. Diverticulitis
● Inflammation or infection of diverticula
● Can be acute or chronic
● May progress to complications
IV. Etiology & Risk Factors
● Low-fiber diet
● Chronic constipation
● Increased intraluminal pressure
● Aging (>40 years)
● Obesity
● Sedentary lifestyle
● Smoking
● NSAID or steroid use
● Genetic predisposition
V. Pathophysiology
1. Low fiber → hard stool
2. ↑ Colonic pressure during defecation
3. Mucosa herniates through weak muscle layer
4. Fecal matter becomes trapped
5. Inflammation and bacterial overgrowth occur
6. Leads to diverticulitis ± complications
VI. Clinical Manifestations
A. Diverticulosis
● Usually asymptomatic
● Intermittent:
○ Abdominal bloating
○ Constipation or diarrhea
○ Mild cramping
● Painless rectal bleeding may occur
B. Diverticulitis
● Left lower quadrant abdominal pain (classic)
● Fever and chills
● Nausea and vomiting
● Change in bowel habits
● Abdominal tenderness
● Leukocytosis
🚨 Signs of complications
● Rigid abdomen
● Severe pain
● Hypotension
● Tachycardia
VII. Diagnostic Evaluation
A. Diverticulosis
● Colonoscopy (after acute phase)
● CT scan
● Barium enema (not during acute inflammation)
B. Diverticulitis
● CT scan of abdomen (diagnostic test of choice)
● CBC: ↑ WBC
● CRP elevated
● Stool studies if bleeding
❌ Colonoscopy contraindicated during acute diverticulitis
VIII. Medical Management
A. Diverticulosis
● High-fiber diet (25–35 g/day)
● Adequate hydration
● Fiber supplements (psyllium)
● Stool softeners
● Regular exercise
B. Diverticulitis (Acute)
Mild (Outpatient)
● Clear liquid diet
● Oral antibiotics
● Analgesics
● Bowel rest
Severe (Inpatient)
● NPO
● IV fluids
● IV antibiotics
● Pain management
● NG tube if ileus present
IX. Surgical Management
Indicated for:
● Perforation
● Abscess
● Fistula
● Obstruction
● Recurrent diverticulitis
● Severe bleeding
Common Procedures
● Bowel resection
● Colostomy (temporary or permanent)
X. Complications
● Perforation
● Peritonitis
● Abscess
● Fistula (colovesical, colovaginal)
● Intestinal obstruction
● Sepsis
● Massive GI bleeding
XI. Nursing Assessment
Assess:
● Abdominal pain location & severity
● Bowel patterns
● Presence of fever
● Signs of bleeding
● Nutritional intake
● Hydration status
● Pain response to treatment
XII. Nursing Interventions
A. Acute Phase (Diverticulitis)
● Maintain NPO status
● Monitor vital signs
● Administer antibiotics as ordered
● Assess abdomen for rigidity
● Monitor WBC count
● Pain management
● Observe for signs of perforation
B. Recovery / Prevention
● Gradually advance diet
● Teach high-fiber diet
● Encourage fluid intake
● Promote physical activity
● Avoid straining during defecation
XIII. Patient Education
● High-fiber foods:
○ Whole grains
○ Fruits
○ Vegetables
○ Legumes
● Avoid constipation
● Respond early to abdominal pain
● No need to avoid seeds/nuts (updated evidence)
● Medication adherence
XIV. NCLEX-Style Key Points
✔ LLQ pain = diverticulitis
✔ CT scan = diagnostic test of choice
✔ NPO during acute inflammation
✔ Colonoscopy contraindicated in acute phase
✔ High-fiber diet for prevention
XV. Diverticulosis vs Diverticulitis
Feature Diverticulosis Diverticulitis
Inflammation No Yes
Pain Minimal/none LLQ pain
Fever No Yes
Treatment Fiber Antibiotics, bowel rest
XVI. Summary
Diverticular disease ranges from asymptomatic diverticulosis to life-threatening
diverticulitis. Early recognition, proper dietary management, and nursing vigilance are
essential to prevent complications and recurrence.
📘 REVIEWER: MALABSORPTION
SYNDROME
I. Definition
Malabsorption is a condition in which the small intestine cannot adequately absorb
nutrients (macronutrients and/or micronutrients) from ingested food, leading to nutritional
deficiencies, weight loss, and systemic complications.
II. Normal Digestion & Absorption (Brief Review)
● Stomach: mechanical digestion, protein breakdown
● Pancreas: digestive enzymes (amylase, lipase, protease)
● Liver/Gallbladder: bile for fat emulsification
● Small Intestine (jejunum & ileum):
○ Main site of nutrient absorption
○ Villi & microvilli increase surface area
III. Pathophysiology
Malabsorption occurs due to:
1. Impaired digestion (lack of enzymes or bile)
2. Damaged intestinal mucosa
3. Decreased absorptive surface area
4. Transport defects
5. Bacterial overgrowth
Result:
● Nutrients remain unabsorbed
● Osmotic diarrhea
● Nutritional deficiencies
● Electrolyte imbalance
IV. Causes of Malabsorption
A. Luminal (Digestive Defects)
● Chronic pancreatitis
● Cystic fibrosis
● Bile duct obstruction
● Liver disease
B. Mucosal (Absorptive Defects)
● Celiac disease
● Crohn’s disease
● Tropical sprue
● Radiation enteritis
● Short bowel syndrome
C. Postmucosal (Transport Defects)
● Lymphatic obstruction
● Intestinal lymphoma
● Whipple’s disease
D. Other Causes
● Lactose intolerance
● Small intestinal bacterial overgrowth (SIBO)
● Medications (orlistat, laxatives)
V. Clinical Manifestations
A. General Symptoms
● Chronic diarrhea
● Steatorrhea (bulky, oily, foul-smelling stool)
● Weight loss
● Fatigue
● Abdominal bloating and cramps
B. Nutrient Deficiency Manifestations
Deficiency Signs & Symptoms
Protein Edema, muscle wasting
Iron Anemia, fatigue
Vitamin B₁₂ Neuropathy, glossitis
Folic acid Megaloblastic anemia
Vitamin D Bone pain, fractures
Vitamin K Bleeding tendency
Calcium Tetany, osteoporosis
Magnesium Arrhythmias
VI. Diagnostic Evaluation
A. Stool Studies
● Fecal fat analysis (↑ fat = malabsorption)
● Stool elastase (pancreatic insufficiency)
B. Blood Tests
● CBC (anemia)
● Electrolytes
● Albumin (↓)
● Vitamin levels
C. Breath Tests
● Hydrogen breath test (lactose intolerance, SIBO)
D. Endoscopy & Biopsy
● Confirms celiac disease or mucosal damage
E. Imaging
● CT scan
● MRI
● Small bowel follow-through
VII. Medical Management
A. Treat Underlying Cause
● Gluten-free diet (celiac disease)
● Antibiotics (SIBO)
● Pancreatic enzyme replacement
● Bile acid supplements
B. Nutritional Therapy
● High-calorie, high-protein diet
● Vitamin and mineral supplementation
● Medium-chain triglycerides (MCTs)
● Enteral or parenteral nutrition if severe
C. Symptom Management
● Antidiarrheals
● Electrolyte replacement
● Lactase enzyme supplements
VIII. Nursing Management
A. Nursing Assessment
● Stool characteristics
● Weight trends
● Signs of nutrient deficiencies
● Dietary intake
● Hydration status
B. Nursing Interventions
● Monitor intake & output
● Administer supplements
● Promote small, frequent meals
● Educate on dietary restrictions
● Prevent skin breakdown due to diarrhea
IX. Patient Education
● Follow prescribed diet strictly
● Read food labels carefully
● Take supplements as ordered
● Recognize deficiency symptoms
● Maintain follow-up appointments
X. Complications
● Severe malnutrition
● Growth failure (children)
● Osteoporosis
● Anemia
● Electrolyte imbalance
● Infection susceptibility
XI. NCLEX-Style Key Points
✔ Steatorrhea = fat malabsorption
✔ Celiac disease damages villi
✔ Vitamin ADEK deficiencies with fat malabsorption
✔ Pancreatic enzymes must be taken with meals
✔ Chronic diarrhea + weight loss = suspect malabsorption
XII. Summary Table
Aspect Key Point
Primary site Small intestine
Hallmark stool Bulky, greasy
Diagnosis Stool fat, biopsy
Management Treat cause + nutrition
Nursing focus Monitor nutrition & hydration
XIII. Memory Aid
“FHere’sAT LOSS”
● Foul stools
● Anemia
● Thin body
● Low vitamins
● Osteoporosis
● Swelling (edema)
● Steatorrhea
📘 REVIEWER: GASTROESOPHAGEAL
REFLUX DISEASE (GERD)
I. Definition
GERD is a chronic condition where stomach contents reflux into the esophagus, causing
symptoms or complications due to LES (lower esophageal sphincter) dysfunction.
● Normal LES prevents reflux.
● In GERD, LES is weak or relaxes inappropriately.
II. Relevant Anatomy & Physiology
● Esophagus: muscular tube that transports food from pharynx to stomach.
● LES: normally closed except during swallowing.
● Diaphragm: supports LES.
● Stomach acid (HCl) can damage esophageal mucosa if refluxed.
Normal Swallowing: peristalsis moves food to stomach → LES closes → prevents reflux.
III. Etiology / Risk Factors
A. LES Dysfunction
● Hypotensive LES (weak)
● Transient LES relaxation
● Hiatal hernia
B. Lifestyle / Dietary Factors
● Obesity
● Large meals
● Alcohol
● Coffee/caffeine
● Fatty, spicy, or acidic foods
● Smoking
C. Other Factors
● Pregnancy (↑ intra-abdominal pressure)
● Delayed gastric emptying (gastroparesis)
● Medications (anticholinergics, calcium channel blockers, NSAIDs)
IV. Pathophysiology
1. LES fails to prevent reflux.
2. Acidic gastric contents irritate esophageal mucosa.
3. Chronic exposure → inflammation (esophagitis), ulceration, and Barrett’s esophagus
(precancerous).
V. Clinical Manifestations
Typical Symptoms
● Heartburn (pyrosis) – retrosternal burning
● Regurgitation – sour or bitter taste
● Dysphagia (difficulty swallowing)
● Chest discomfort
● Epigastric pain
Atypical / Extraesophageal Symptoms
● Chronic cough
● Laryngitis / hoarseness
● Asthma exacerbation
● Dental erosion
● Sore throat
VI. Complications
● Esophagitis
● Esophageal stricture → dysphagia
● Barrett’s esophagus → ↑ risk of adenocarcinoma
● Esophageal ulceration → bleeding
● Respiratory issues (aspiration pneumonia, chronic cough)
● Dental erosions
VII. Diagnostic Evaluation
A. Clinical Diagnosis
● Based on symptoms (heartburn ≥2x/week)
B. Tests
● Endoscopy (EGD): detects esophagitis, Barrett’s esophagus
● 24-hour pH monitoring: gold standard for acid reflux
● Esophageal manometry: LES pressure & motility
● Barium swallow: evaluates hiatal hernia, strictures
VIII. Medical Management
A. Lifestyle Modifications
● Small, frequent meals
● Avoid lying down 2–3 hours after eating
● Elevate head of bed (6–8 inches)
● Weight loss
● Avoid trigger foods (spicy, fatty, caffeine, alcohol)
● Stop smoking
B. Pharmacologic Therapy
Drug Class Examples Mechanism
Antacids Aluminum hydroxide, Neutralize stomach acid
magnesium hydroxide
H2 receptor blockers Famotidine, Ranitidine ↓ gastric acid production
Proton pump inhibitors (PPI) Omeprazole, Pantoprazole Inhibit H⁺/K⁺ ATPase → ↓ acid
Prokinetics Metoclopramide ↑ gastric emptying, LES tone
Note: PPIs are first-line for moderate to severe GERD.
C. Surgical Management
Indicated for:
● Refractory GERD
● Severe complications (strictures, Barrett’s)
● Hiatal hernia repair
Procedures
● Nissen fundoplication: wraps gastric fundus around LES
● Laparoscopic antireflux surgery
IX. Nursing Assessment
● Frequency, timing, and severity of heartburn
● Regurgitation, dysphagia
● Weight changes
● Respiratory symptoms
● Medication adherence
● Lifestyle habits
X. Nursing Interventions
A. Independent
● Encourage lifestyle modifications
● Positioning: upright after meals
● Educate on trigger foods
● Promote weight loss
● Encourage small, frequent meals
B. Collaborative
● Administer prescribed medications (antacids, H2 blockers, PPIs)
● Monitor for side effects (diarrhea, constipation)
● Prepare patient for diagnostic tests or surgery
● Monitor for complications (bleeding, aspiration)
XI. Patient Education
● Avoid tight clothing
● Avoid meals 2–3 hours before bedtime
● Elevate head of bed
● Adhere to medication regimen
● Recognize red flags: severe chest pain, vomiting blood, black stools
● Smoking cessation
● Weight management
XII. NCLEX-Style Key Points
✔ Heartburn 2+ times/week → consider GERD
✔ PPIs = first-line for chronic GERD
✔ Lifestyle changes reduce symptoms
✔ Complication: Barrett’s esophagus → cancer risk
✔ Surgical option: Nissen fundoplication
XIII. Summary Table
Feature GERD
Definition Reflux of stomach contents into esophagus
Risk Factors Obesity, pregnancy, hiatal hernia, diet,
smoking
Symptoms Heartburn, regurgitation, dysphagia
Complications Esophagitis, stricture, Barrett’s esophagus,
aspiration
Diagnosis Clinical, EGD, 24-hr pH monitoring
Treatment Lifestyle, medications, surgery if severe
📘 REVIEWER: IRRITABLE BOWEL
SYNDROME (IBS)
I. Definition
IBS is a functional gastrointestinal disorder characterized by chronic abdominal pain or
discomfort associated with altered bowel habits without identifiable structural or biochemical
abnormalities.
● It is a diagnosis of exclusion.
● Most common functional GI disorder in adults.
II. Pathophysiology
● Exact cause unknown; multifactorial:
1. Altered gut motility – rapid or slow transit
2. Visceral hypersensitivity – increased pain perception
3. Gut-brain axis dysregulation – stress, anxiety
4. Intestinal inflammation or microbiota imbalance
5. Post-infectious changes – after gastroenteritis
6. Food intolerance – lactose, FODMAPs
III. Risk Factors
● Female gender (2:1 ratio)
● Age <50 years
● Stress and anxiety
● Family history
● History of gastroenteritis
● Food intolerances
IV. Clinical Manifestations
A. Common Symptoms
● Abdominal pain or cramping relieved by defecation
● Bloating, gas
● Altered bowel habits:
○ IBS-C (constipation predominant)
○ IBS-D (diarrhea predominant)
○ IBS-M (mixed)
● Urgency or incomplete evacuation
B. Alarm Symptoms (Red Flags) – Rule Out Organic Disease
● GI bleeding
● Unexplained weight loss
● Fever
● Anemia
● Nocturnal diarrhea
● Family history of colon cancer, IBD
V. Diagnostic Evaluation
● Diagnosis is clinical (Rome IV Criteria):
○ Recurrent abdominal pain ≥1 day/week in the last 3 months
○ Associated with ≥2 of:
1. Related to defecation
2. Change in stool frequency
3. Change in stool form or appearance
● Tests to rule out organic disease:
○ CBC, CRP
○ Stool studies
○ Colonoscopy (if red flags present)
○ Lactose breath test (if lactose intolerance suspected)
VI. Types of IBS
Type Features
IBS-C Hard or lumpy stools ≥25% of bowel
movements, <25% loose stools
IBS-D Loose or watery stools ≥25% of bowel
movements, <25% hard stools
IBS-M Mixed constipation and diarrhea
IBS-U Unclassified
VII. Management
A. Lifestyle & Dietary Modifications
● Increase dietary fiber (soluble fiber for IBS-C)
● Avoid trigger foods (FODMAPs, caffeine, alcohol, fatty foods)
● Eat small, frequent meals
● Maintain adequate hydration
● Regular exercise
● Stress management (yoga, meditation, CBT)
B. Pharmacologic Therapy
Symptom Medication
IBS-C Fiber supplements (psyllium), osmotic
laxatives, lubiprostone, linaclotide
IBS-D Loperamide, bile acid sequestrants, rifaximin
Abdominal pain / bloating Antispasmodics (dicyclomine), peppermint oil,
low-dose antidepressants (TCA/SSRI)
Note: Medications are symptom-based; no cure exists.
C. Psychological Interventions
● Cognitive-behavioral therapy (CBT)
● Hypnotherapy
● Mindfulness therapy
VIII. Nursing Assessment
● Frequency, consistency, and color of stools
● Abdominal pain patterns
● Triggers (food, stress)
● Impact on daily activities
● Nutritional status
● Bowel diary
IX. Nursing Interventions
● Encourage dietary modifications
● Promote stress reduction techniques
● Monitor for complications (e.g., dehydration with IBS-D)
● Educate patient on symptom tracking
● Administer medications as prescribed
● Provide emotional support
X. Patient Education
● Keep a food and symptom diary
● Identify and avoid trigger foods
● Increase soluble fiber gradually
● Stay hydrated
● Exercise regularly
● Stress management strategies
● Educate that IBS is chronic but not life-threatening
XI. Complications
● Dehydration (with severe diarrhea)
● Hemorrhoids (straining)
● Anxiety or depression
● Social or work-life impairment
● Nutritional deficiencies (rare)
XII. NCLEX-Style Key Points
✔ Rome IV criteria used for diagnosis
✔ IBS is a functional disorder – no structural damage
✔ Treatment is symptom-based (diet, meds, stress management)
✔ Differentiate IBS from IBD or colon cancer (watch for red flags)
✔ Fiber helps constipation; avoid insoluble fiber for IBS-D
XIII. Summary Table
Aspect Key Points
Definition Chronic abdominal pain + altered bowel
habits without organic disease
Risk Factors Female, stress, age <50, post-infection, food
triggers
Types IBS-C, IBS-D, IBS-M, IBS-U
Diagnosis Rome IV criteria, rule out red flags
Treatment Lifestyle, diet, meds, stress management
Nursing Focus Symptom monitoring, dietary guidance,
emotional support
📘 REVIEWER: LIVER CANCER
I. Definition
Liver cancer is a malignant growth of hepatocytes or bile duct cells in the liver.
Types:
1. Primary Liver Cancer
○ Hepatocellular carcinoma (HCC) – most common
○ Cholangiocarcinoma – arises from bile ducts
2. Secondary (Metastatic) Liver Cancer
○ From colon, breast, lung, pancreas, or other cancers
II. Relevant Anatomy & Physiology
● Liver: largest internal organ; functions:
○ Metabolism of nutrients, drugs
○ Protein synthesis (albumin, clotting factors)
○ Detoxification
○ Bile production
● Hepatic blood supply: dual – portal vein (70%) + hepatic artery (30%)
● Liver cells can regenerate, but chronic damage ↑ risk for cancer
III. Etiology / Risk Factors
A. Hepatocellular Carcinoma (Primary)
● Chronic hepatitis B virus (HBV)
● Chronic hepatitis C virus (HCV)
● Cirrhosis (alcoholic, NASH, autoimmune)
● Aflatoxin exposure
● Male gender, age >50
B. Cholangiocarcinoma
● Primary sclerosing cholangitis
● Liver flukes (Opisthorchis, Clonorchis)
● Chronic biliary inflammation
C. Secondary Liver Cancer
● Most commonly from colorectal cancer
● Breast, lung, pancreatic metastasis
IV. Pathophysiology
1. Chronic liver injury → fibrosis → cirrhosis
2. Dysplasia → neoplastic transformation of hepatocytes
3. Tumor growth leads to:
○ Disruption of normal liver architecture
○ Portal hypertension
○ Impaired detoxification and protein synthesis
4. Metastatic spread via portal vein or systemic circulation
V. Clinical Manifestations
Early Stage (Often Asymptomatic)
● Usually no symptoms
● Detected incidentally on imaging or labs
Late Stage
● Abdominal pain or right upper quadrant fullness
● Hepatomegaly
● Unexplained weight loss
● Fatigue, malaise
● Jaundice
● Nausea, vomiting
● Ascites
● Pruritus
● Easy bruising/bleeding (clotting factor deficiency)
● Fever (paraneoplastic syndrome)
VI. Complications
● Liver failure
● Portal hypertension
● Ascites
● Hepatic encephalopathy
● Spontaneous rupture → internal bleeding
● Metastasis (lungs, bones, lymph nodes)
VII. Diagnostic Evaluation
A. Laboratory Tests
● Liver function tests (LFTs): ↑ AST, ALT, bilirubin; ↓ albumin
● Alpha-fetoprotein (AFP): elevated in HCC (not specific)
● CBC, coagulation profile
B. Imaging
● Ultrasound (screening)
● CT scan with contrast (diagnostic)
● MRI – better for tumor characterization
● Doppler for vascular involvement
C. Biopsy
● Percutaneous or transjugular liver biopsy
● Confirms histology (if imaging inconclusive)
VIII. Staging
● TNM system (Tumor, Node, Metastasis)
● Barcelona Clinic Liver Cancer (BCLC) staging guides treatment
● Factors: tumor size, vascular invasion, metastasis, liver function, performance status
IX. Medical Management
A. Curative (for localized disease)
● Surgical resection – if adequate liver function
● Liver transplantation – for eligible cirrhotic patients
B. Local/Regional Therapy
● Radiofrequency ablation
● Transarterial chemoembolization (TACE)
● Microwave ablation
● Selective internal radiation therapy (SIRT)
C. Systemic Therapy
● Targeted therapy (sorafenib, lenvatinib)
● Immunotherapy (atezolizumab + bevacizumab)
● Chemotherapy (rarely used, limited efficacy)
D. Palliative Care
● Symptom management: pain, ascites, nausea
● Nutritional support
● Emotional support
X. Nursing Assessment
● Monitor abdominal girth, weight
● Evaluate pain location, severity
● Assess jaundice, pruritus, bleeding
● Observe for ascites, edema
● Review labs: LFTs, AFP, coagulation profile
● Assess psychosocial needs
XI. Nursing Interventions
● Administer medications (analgesics, diuretics, targeted therapy)
● Monitor vital signs and fluid balance
● Prepare patient for procedures (biopsy, surgery, TACE)
● Provide skin care for jaundice/pruritus
● Educate patient and family about disease, treatment, and prognosis
● Emotional and spiritual support
XII. Patient Education
● Avoid alcohol
● Adhere to prescribed treatment
● Report signs of bleeding or encephalopathy
● Maintain nutrition (small, frequent meals; high-protein diet if not restricted)
● Follow-up for imaging and labs
● Vaccination for hepatitis (if not already immune)
XIII. NCLEX-Style Key Points
✔ HCC often develops in cirrhotic liver
✔ AFP is screening & monitoring, not diagnostic alone
✔ Surgery/transplantation = curative if feasible
✔ TACE or ablation for localized unresectable tumors
✔ Monitor for ascites, jaundice, coagulopathy
XIV. Summary Table
Feature Key Points
Most common primary type Hepatocellular carcinoma (HCC)
Risk factors HBV/HCV, cirrhosis, aflatoxin, alcohol, NASH
Symptoms Abdominal pain, weight loss, jaundice,
ascites
Diagnosis LFTs, AFP, ultrasound, CT/MRI, biopsy
Treatment Surgery, transplant, ablation, systemic
therapy
Nursing focus Pain, nutrition, fluid balance, psychosocial
support
📘 REVIEWER: INTESTINAL
OBSTRUCTION
I. Definition
Intestinal obstruction is a partial or complete blockage of the intestinal lumen, preventing
the normal flow of intestinal contents.
● Can occur in the small intestine (most common) or large intestine.
● Obstruction may be mechanical (physical blockage) or functional (paralytic ileus).
II. Relevant Anatomy & Physiology
● Small intestine: duodenum, jejunum, ileum – nutrient absorption occurs here.
● Large intestine: colon – water absorption and stool formation.
● Normal peristalsis: propels contents; obstruction interrupts this flow.
● Consequences: proximal bowel dilation, increased secretions, fluid/electrolyte
imbalance, ischemia.
III. Types of Obstruction
A. Mechanical Obstruction
● Adhesions (post-surgical) – most common in small intestine
● Hernias (inguinal, femoral, umbilical)
● Tumors (colon cancer)
● Volvulus – twisting of bowel
● Intussusception – telescoping of bowel
● Foreign bodies / impacted feces
B. Functional Obstruction (Ileus)
● Paralytic ileus – impaired peristalsis
● Causes:
○ Postoperative
○ Peritonitis
○ Electrolyte imbalance (↓ K⁺, ↓ Mg²⁺)
○ Medications (opioids, anticholinergics)
IV. Etiology / Risk Factors
● Abdominal surgery (adhesions)
● Hernia
● Tumors (colorectal)
● Inflammatory bowel disease (Crohn’s)
● Older age (risk of volvulus)
● Medications that slow bowel motility
V. Pathophysiology
1. Obstruction → proximal bowel dilation
2. ↑ Intramural pressure → impaired venous and lymphatic flow
3. Bacterial overgrowth → distension, fluid accumulation
4. Complications: ischemia, necrosis, perforation, sepsis
VI. Clinical Manifestations
A. Small Bowel Obstruction
● Rapid onset
● Crampy, intermittent abdominal pain
● Nausea and vomiting (may be bilious)
● Abdominal distension (mild initially)
● Hyperactive bowel sounds early, hypoactive later
● Obstipation (no stool or flatus)
B. Large Bowel Obstruction
● Gradual onset
● Abdominal distension more pronounced
● Mild, crampy pain
● Constipation or obstipation
● Vomiting late
● Tympanic bowel sounds
C. Complications
● Strangulation → severe pain, fever, tachycardia
● Ischemia → necrosis → perforation → peritonitis → shock
VII. Diagnostic Evaluation
A. Laboratory Tests
● CBC: leukocytosis if infection or ischemia
● Electrolytes: Na⁺, K⁺, Cl⁻ (vomiting → hypokalemic metabolic alkalosis)
● BUN/Creatinine: dehydration
B. Imaging
● Abdominal X-ray: dilated loops, air-fluid levels
● CT scan with contrast: identifies level, cause, and complications
● Ultrasound: useful in children (intussusception) or hernia
VIII. Medical Management
A. Initial / Supportive Care
● NPO (nothing by mouth)
● IV fluids (correct dehydration, electrolytes)
● NG tube insertion for decompression
● Pain management (careful with opioids)
● Monitor vital signs and urine output
B. Pharmacologic
● Analgesics (short-acting opioids)
● Antiemetics (ondansetron, metoclopramide)
● Treat underlying cause (antibiotics if peritonitis suspected)
C. Definitive Treatment
● Mechanical obstruction: surgery if complete, strangulated, or failed conservative
management
● Ileus: supportive care; usually resolves spontaneously
IX. Surgical Management
Indications:
● Complete obstruction
● Signs of ischemia or perforation
● Failure of conservative therapy
Common procedures:
● Resection of necrotic bowel
● Adhesiolysis
● Colostomy / ileostomy (temporary or permanent)
X. Nursing Assessment
● Assess bowel sounds (hyperactive → hypoactive)
● Monitor abdominal distension
● Pain assessment
● Vomiting: characteristics, frequency
● Intake and output
● Signs of dehydration
● Vital signs (tachycardia, hypotension, fever)
XI. Nursing Interventions
● Maintain NPO status
● Insert and manage NG tube
● Administer IV fluids and electrolytes
● Pain control without masking worsening pain
● Monitor for complications (perforation, sepsis)
● Prepare for surgery
● Educate patient and family
XII. Patient Education
● Post-surgical adhesions are common cause
● Avoid foods that may cause obstruction (high-residue foods if prone)
● Recognize early symptoms: abdominal pain, vomiting, bloating
● Follow-up for bowel habits
XIII. Complications
● Strangulation → necrosis
● Bowel perforation → peritonitis
● Sepsis → shock
● Electrolyte imbalance
● Dehydration
● Malnutrition (if prolonged obstruction)
XIV. NCLEX-Style Key Points
✔ Small bowel obstruction → vomiting early, rapid onset
✔ Large bowel obstruction → gradual onset, distension prominent
✔ NPO + NG tube + IV fluids = initial management
✔ Surgery indicated for complete obstruction or ischemia
✔ Monitor for electrolyte imbalance and hypovolemic shock
XV. Summary Table
Feature Small Bowel Large Bowel
Onset Rapid Gradual
Pain Crampy, intermittent Mild, colicky
Vomiting Early, bile-stained Late
Distension Mild Marked
Stool Obstipation early Obstipation or constipation
Bowel sounds Hyperactive early May be hypoactive